Adaptive Biotechnologies Launches Enhanced clonoSEQ® Assay Reports for Patients with Chronic…
SEATTLE, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to…